Laherradurin Inhibits Colorectal Cancer Cell Growth by Induction of Mitochondrial Dysfunction and Autophagy Induction

LAH, an acetogenin from the Annonaceae family, has demonstrated antitumor activity in several cancer cell lines and in vivo models, where it reduced the tumor size and induced programmed cell death. We focused on the effects of LAH on mitochondrial dynamics, mTOR signaling, autophagy, and apoptosis...

Full description

Saved in:
Bibliographic Details
Main Authors: Izamary Delgado-Waldo, Svetlana Dokudovskaya, Yahir A. Loissell-Baltazar, Eduardo Pérez-Arteaga, Jossimar Coronel-Hernández, Mariano Martínez-Vázquez, Eloy Andrés Pérez-Yépez, Alejandro Lopez-Saavedra, Nadia Jacobo-Herrera, Carlos Pérez Plasencia
Format: Article
Language:English
Published: MDPI AG 2024-10-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/13/19/1649
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850283782835273728
author Izamary Delgado-Waldo
Svetlana Dokudovskaya
Yahir A. Loissell-Baltazar
Eduardo Pérez-Arteaga
Jossimar Coronel-Hernández
Mariano Martínez-Vázquez
Eloy Andrés Pérez-Yépez
Alejandro Lopez-Saavedra
Nadia Jacobo-Herrera
Carlos Pérez Plasencia
author_facet Izamary Delgado-Waldo
Svetlana Dokudovskaya
Yahir A. Loissell-Baltazar
Eduardo Pérez-Arteaga
Jossimar Coronel-Hernández
Mariano Martínez-Vázquez
Eloy Andrés Pérez-Yépez
Alejandro Lopez-Saavedra
Nadia Jacobo-Herrera
Carlos Pérez Plasencia
author_sort Izamary Delgado-Waldo
collection DOAJ
description LAH, an acetogenin from the Annonaceae family, has demonstrated antitumor activity in several cancer cell lines and in vivo models, where it reduced the tumor size and induced programmed cell death. We focused on the effects of LAH on mitochondrial dynamics, mTOR signaling, autophagy, and apoptosis in colorectal cancer (CRC) cells to explore its anticancer potential. Methods: CRC cells were treated with LAH, and its effects on mitochondrial respiration and glycolysis were measured using Seahorse XF technology. The changes in mitochondrial dynamics were observed through fluorescent imaging, while Western blot analysis was used to examine key autophagy and apoptosis markers. Results: LAH significantly inhibited mitochondrial complex I activity, inducing ATP depletion and a compensatory increase in glycolysis. This disruption caused mitochondrial fragmentation, a trigger for autophagy, as shown by increased LC3-II expression and mTOR suppression. Apoptosis was also confirmed through the cleavage of caspase-3, contributing to reduced cancer cell viability. Conclusions: LAH’s anticancer effects in CRC cells are driven by its disruption of mitochondrial function, triggering both autophagy and apoptosis. These findings highlight its potential as a therapeutic compound for further exploration in cancer treatment.
format Article
id doaj-art-e25dedf5fe1b4b50b7245cfa7cd433c4
institution OA Journals
issn 2073-4409
language English
publishDate 2024-10-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj-art-e25dedf5fe1b4b50b7245cfa7cd433c42025-08-20T01:47:42ZengMDPI AGCells2073-44092024-10-011319164910.3390/cells13191649Laherradurin Inhibits Colorectal Cancer Cell Growth by Induction of Mitochondrial Dysfunction and Autophagy InductionIzamary Delgado-Waldo0Svetlana Dokudovskaya1Yahir A. Loissell-Baltazar2Eduardo Pérez-Arteaga3Jossimar Coronel-Hernández4Mariano Martínez-Vázquez5Eloy Andrés Pérez-Yépez6Alejandro Lopez-Saavedra7Nadia Jacobo-Herrera8Carlos Pérez Plasencia9Unidad de Bioquímica, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Av. Vasco de Quiroga 15, Col. Belisario Domínguez Sección XVI, Tlalpan, Ciudad de México 14080, MexicoCNRS UMR9018, Institut Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, FranceCNRS UMR9018, Institut Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, FranceUnidad de Bioquímica, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Av. Vasco de Quiroga 15, Col. Belisario Domínguez Sección XVI, Tlalpan, Ciudad de México 14080, MexicoLaboratorio de Genómica, Instituto Nacional de Cancerología, Instituto Nacional Nacional de Cancerología, Av. San Fernando 22, Belisario Domínguez Secc 16, Tlalpan, Ciudad de México 14080, MexicoInstituto de Química, Universidad Nacional Autónoma de México, C. Exterior, C. Universitaria, Coyoacán, Ciudad de México 04510, MexicoLaboratorio de Genómica, Instituto Nacional de Cancerología, Instituto Nacional Nacional de Cancerología, Av. San Fernando 22, Belisario Domínguez Secc 16, Tlalpan, Ciudad de México 14080, MexicoAdvanced Microscopy Applications Unit (ADMIRA), Instituto Nacional de Cancerología, San Fernando 22. Col. Sección XVI, Tlalpan, Ciudad de México 14080, MexicoUnidad de Bioquímica, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Av. Vasco de Quiroga 15, Col. Belisario Domínguez Sección XVI, Tlalpan, Ciudad de México 14080, MexicoLaboratorio de Genómica, Instituto Nacional de Cancerología, Instituto Nacional Nacional de Cancerología, Av. San Fernando 22, Belisario Domínguez Secc 16, Tlalpan, Ciudad de México 14080, MexicoLAH, an acetogenin from the Annonaceae family, has demonstrated antitumor activity in several cancer cell lines and in vivo models, where it reduced the tumor size and induced programmed cell death. We focused on the effects of LAH on mitochondrial dynamics, mTOR signaling, autophagy, and apoptosis in colorectal cancer (CRC) cells to explore its anticancer potential. Methods: CRC cells were treated with LAH, and its effects on mitochondrial respiration and glycolysis were measured using Seahorse XF technology. The changes in mitochondrial dynamics were observed through fluorescent imaging, while Western blot analysis was used to examine key autophagy and apoptosis markers. Results: LAH significantly inhibited mitochondrial complex I activity, inducing ATP depletion and a compensatory increase in glycolysis. This disruption caused mitochondrial fragmentation, a trigger for autophagy, as shown by increased LC3-II expression and mTOR suppression. Apoptosis was also confirmed through the cleavage of caspase-3, contributing to reduced cancer cell viability. Conclusions: LAH’s anticancer effects in CRC cells are driven by its disruption of mitochondrial function, triggering both autophagy and apoptosis. These findings highlight its potential as a therapeutic compound for further exploration in cancer treatment.https://www.mdpi.com/2073-4409/13/19/1649laherradurinacetogeninscolon cancermitochondriaautophagyapoptosis
spellingShingle Izamary Delgado-Waldo
Svetlana Dokudovskaya
Yahir A. Loissell-Baltazar
Eduardo Pérez-Arteaga
Jossimar Coronel-Hernández
Mariano Martínez-Vázquez
Eloy Andrés Pérez-Yépez
Alejandro Lopez-Saavedra
Nadia Jacobo-Herrera
Carlos Pérez Plasencia
Laherradurin Inhibits Colorectal Cancer Cell Growth by Induction of Mitochondrial Dysfunction and Autophagy Induction
Cells
laherradurin
acetogenins
colon cancer
mitochondria
autophagy
apoptosis
title Laherradurin Inhibits Colorectal Cancer Cell Growth by Induction of Mitochondrial Dysfunction and Autophagy Induction
title_full Laherradurin Inhibits Colorectal Cancer Cell Growth by Induction of Mitochondrial Dysfunction and Autophagy Induction
title_fullStr Laherradurin Inhibits Colorectal Cancer Cell Growth by Induction of Mitochondrial Dysfunction and Autophagy Induction
title_full_unstemmed Laherradurin Inhibits Colorectal Cancer Cell Growth by Induction of Mitochondrial Dysfunction and Autophagy Induction
title_short Laherradurin Inhibits Colorectal Cancer Cell Growth by Induction of Mitochondrial Dysfunction and Autophagy Induction
title_sort laherradurin inhibits colorectal cancer cell growth by induction of mitochondrial dysfunction and autophagy induction
topic laherradurin
acetogenins
colon cancer
mitochondria
autophagy
apoptosis
url https://www.mdpi.com/2073-4409/13/19/1649
work_keys_str_mv AT izamarydelgadowaldo laherradurininhibitscolorectalcancercellgrowthbyinductionofmitochondrialdysfunctionandautophagyinduction
AT svetlanadokudovskaya laherradurininhibitscolorectalcancercellgrowthbyinductionofmitochondrialdysfunctionandautophagyinduction
AT yahiraloissellbaltazar laherradurininhibitscolorectalcancercellgrowthbyinductionofmitochondrialdysfunctionandautophagyinduction
AT eduardoperezarteaga laherradurininhibitscolorectalcancercellgrowthbyinductionofmitochondrialdysfunctionandautophagyinduction
AT jossimarcoronelhernandez laherradurininhibitscolorectalcancercellgrowthbyinductionofmitochondrialdysfunctionandautophagyinduction
AT marianomartinezvazquez laherradurininhibitscolorectalcancercellgrowthbyinductionofmitochondrialdysfunctionandautophagyinduction
AT eloyandresperezyepez laherradurininhibitscolorectalcancercellgrowthbyinductionofmitochondrialdysfunctionandautophagyinduction
AT alejandrolopezsaavedra laherradurininhibitscolorectalcancercellgrowthbyinductionofmitochondrialdysfunctionandautophagyinduction
AT nadiajacoboherrera laherradurininhibitscolorectalcancercellgrowthbyinductionofmitochondrialdysfunctionandautophagyinduction
AT carlosperezplasencia laherradurininhibitscolorectalcancercellgrowthbyinductionofmitochondrialdysfunctionandautophagyinduction